Obizur
Obizur
Product Specs | Obizur |
---|---|
Manufacturer Name | Takeda |
Indications | OBIZUR, Antihemophilic Factor (Recombinant), Porcine Sequence, is an antihemophilic factor indicated for the on-demand treatment and control of bleeding episodes in adults with acquired hemophilia A. |
Contraindications | Do not use in patients who have had life-threatening hypersensitivity reactions to OBIZUR or its components, including hamster protein. |
Manufacturing Methods | Genetically engineered baby hamster kidney (BHK) cell line which secretes rpFVIII into the cell culture medium |
Viral Safety Process | Chromatography, solvent/detergent treatment, nanofiltration |
Route of Administration | Intravenous |
Product Half-Life | Range 2.6 to 28.6 hours |
Shelf Life | Listed on label |
Storage Requirements |
|
Available Formulations | When reconstituted with the diluent, the product contains the following components per mL: 8.8 mg sodium chloride, 0.04 mg Tris-base, 0.73 mg Tris-HCl, 1.47 mg trisodium citrate dehydrate, 0.15 mg calcium chloride dehydrate, 1.9 mg sucrose, and 0.05 mg polysorbate 80 |
Return to Manufacturer Name listing Return to Factor Type listing